Prediction of response to recombinant human erythropoietin (rHuEpo) in anemia of malignancy.

Abstract

This retrospective analysis suggests that response to rHuEpo can be reasonably predicted by pretreatment serum erythropoietin together with early changes in simple laboratory parameters.